Khan AM, Dvorak K, Zhao Q, Bumma N, Cottini F, Devarakonda S, Umyarova E, Sharma N, Benson D, Rosko A. Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myeloma. haematol [Internet]. 2023Dec.1 [cited 2024Oct.6];108(12):3477-9. Available from: https://haematologica.org/article/view/haematol.2022.282521